Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
5.12
-0.18 (-3.40%)
Apr 29, 2026, 11:55 AM EDT - Market open
Zura Bio Market Cap
Zura Bio has a market cap or net worth of $485.79 million as of April 29, 2026. Its market cap has increased by 487.17% in one year.
Market Cap
485.79M
Enterprise Value
393.46M
1-Year Change
487.17%
Ranking
Category
Stock Price
$5.12
Market Cap Chart
Since September 3, 2021, Zura Bio's market cap has increased from $167.33M to $485.79M, an increase of 190.33%. That is a compound annual growth rate of 25.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 502.87M | 47.59% |
| Dec 31, 2025 | 340.72M | 108.73% |
| Dec 31, 2024 | 163.23M | -19.82% |
| Dec 29, 2023 | 203.58M | 15.59% |
| Dec 30, 2022 | 176.12M | 3.44% |
| Dec 31, 2021 | 170.26M | 1.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AgomAb Therapeutics NV | 538.54M |
| Tectonic Therapeutic | 535.88M |
| enGene Therapeutics | 535.25M |
| Lyell Immunopharma | 522.79M |
| Eikon Therapeutics | 522.71M |
| Immix Biopharma | 522.17M |
| Fulcrum Therapeutics | 522.15M |
| Verastem | 519.15M |